Breast cancer and public healthcare: survey and proposals from Brazilian Society of Mastology (SBM)
DOI:
https://doi.org/10.29289/2594539420240014%20Keywords:
public health surveillance, breast neoplasms, healthcare disparities, health inequities, socioeconomic factorsAbstract
Introduction: High rates of breast cancer mortality have been reported for patients from public healthcare, in Brazil. This study aimed to obtain a panorama of breast cancer in public healthcare, based on a questionnaire sent to breast specialists. Methods: Active members of the Brazilian Society of Mastology (SBM) were invited to participate anonymously, from Aug-Oct 2023. Possible answers ranged from “This is not a problem” to “This is a very serious, very common problem”. The primary endpoint of the study was the relative frequency of the answers. Results: Overall, 767 (44% of all SBM affiliated members) completed the questionnaire. Access to modern drugs was considered the most concerning problem, with 81.36% of respondents classifying this as “serious, frequently” or “very serious, very frequently”, followed by access to diagnostic methods (64.53%), access to breast reconstruction (60.24%), delay in starting treatment (60.11%) and access to screening (51.76%). Conclusions: This is the first study to evaluate the perceptions of breast specialists on breast cancer care within SUS. The SBM has issued considerations and proposals aimed at reestablishing a minimally adequate standard of breast cancer diagnosis and treatment in public healthcare in Brazil.
Downloads
References
1. Malta DC, Stopa SR, Pereira CA, Szwarcwald CL, Oliveira M, Reis AC. Cobertura de Planos de Saúde na população brasileira, segundo a Pesquisa Nacional de Saúde, 2013. Ciênc Saúde Colet. 2017;22(1):179-90. https://doi.org/10.1590/1413-81232017221.16782015
2. Liedke PER, Finkelstein DM, Szymonifka J, Barrios CH, Chavarri-Guerra Y, Bines J, et al. Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study. Cancer Epidemiol Biomarkers Prev. 2014;23(1):126-33. https://doi.org/10.1158/1055-9965.EPI-13-0693
3. Marta G, Frederice R, Andrade F, Hanna S, Carvalho H, Pereira A. Determinants of health and survival on Brazilian patients with breast cancer: populational database [Internet]. ESTRO Presentation Number: PD-0747. Copenhagen, Denmark, 6–10 May 2022 [cited on 2024 Mar 22]. Available from: https://www.estro.org/Congresses/ESTRO-2022/618/18-breast/10378/determinantsofhealthandsurvivalonbrazilianpatients
4. Rosa DD, Bines J, Werutsky G, Barrios CH, Cronemberger E, Queiroz GS, et al. The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115). Breast Cancer Res Treat. 2020;183(3):749-57. https://doi.org/10.1007/s10549-020-05831-y
5. Instituto Nacional de Câncer José Alencar Gomes da Silva. A situação do câncer de mama no Brasil: síntese de dados dos sistemas de informação. Rio de Janeiro: INCA; 2019.
6. Freitas-Junior R, Rocha AFBM, Soares LR. Mammography coverage in Brazil and the presidential elections: is there anything to celebrate? JCO Glob Oncol. 2023;9:e2200358. https://doi.org/10.1200/GO.22.00358
7. Cuoghi IC, Soares MFS, Santos GMC, Dos-Reis FJC, Poli-Neto OB, Andrade JM, et al. 10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study. J Glob Health. 2022;12:04061. https://doi.org/10.7189/jogh.12.04061
8. Tomazelli JG, Silva GA. Rastreamento do câncer de mama no Brasil: uma avaliação da oferta e utilização da rede assistencial do Sistema Único de Saúde no período 2010-2012*. Epidemiol Serv Saúde. 2017;26(4):713-24. https://doi.org/10.5123/S1679-49742017000400004
9. An D, Choi J, Lee J, Kim JY, Kwon S, Kim J, et al. Time to surgery and survival in breast cancer. BMC Surg. 2022;22(1):388. https://doi.org/10.1186/s12893-022-01835-1
10. Yu KD, Huang S, Zhang JX, Liu GY, Shao ZM. Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis. BMC Cancer. 2013;13(1):240. https://doi.org/10.1186/1471-2407-13-240
11. Almeida CSC, Morais RXB, França IR, Cavalcante KWM, Santos ALBN, Morais BXB, et al. Comparative analysis of mastectomies and breast reconstructions performed in the Brazilian Unified Health System in the last 5 years. Rev Bras Cir Plást. 2021;36(3):263-9. https://doi.org/10.5935/2177-1235.2021RBCP0039
12. Freitas‐Júnior R, Gagliato DM, Moura Filho JWC, Gouveia PA, Rahal RMS, Paulinelli RR, et al. Trends in breast cancer surgery at Brazil’s public health system. J Surg Oncol. 2017;115(5):544-9. https://doi.org/10.1002/jso.24572
13. Urban C, Gazoto Júnior O, Pires DM, Garcia GN, Paulinelli RR, Amoroso V, et al. Trends and attitudes toward oncoplastics training in Mastology in Brazil. Mastology. 2017;27(3):182-6. https://doi.org/10.5327/Z2594539420170000221
14. Comissão Nacional de Incorporação de Tecnologias no SUS. Diretrizes diagnósticas e terapêuticas do carcinoma de mama. Relatório de recomendação. Brasília: Ministério da Saúde; 2018.
15. Kaliks RA, Matos TF, Siva V, Barros LHC. Differences in systemic cancer treatment in Brazil: my Public Health System is different from your Public Health System. Braz J Oncol. 2017;13(44):1-12.
16. Ugai T, Sasamoto N, Lee HY, Ando M, Song M, Tamimi RM, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022;19(10):656-73. https://doi.org/10.1038/s41571-022-00672-8
17. Orlandini LF, Antonio MVN, Espreafico Jr CR, Bosquesi PL, Poli-Neto OB, Andrade JM, et al. Epidemiological analyses reveal a high incidence of breast cancer in young women in Brazil. JCO Glob Oncol. 2021;(7):81-8. https://doi.org/10.1200/GO.20.00440
18. Bonadio RC, Moreira OA, Testa L. Breast cancer trends in women younger than 40 years in Brazil. Cancer Epidemiol. 2022;78:102139. https://doi.org/10.1016/j.canep.2022.102139
19. Chen T, Kharazmi E, Fallah M. Race and ethnicity-adjusted age recommendation for initiating breast cancer screening. JAMA Netw Open. 2023;6(4):e238893. https://doi.org/10.1001/jamanetworkopen.2023.8893
20. U.S. Preventive Services Task Force. Draft recommendation statement. Breast cancer: screening [Internet]. 2023 [cited on 2024 Mar 22]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementDraft/breast-cancer-screening
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Augusto Tufi Hassan, Jordana de Faria Bessa, Guilherme Garcia Novita, Sandra Gioia, André Mattar, Francisco Pimentel Cavalcante, Ruffo Freitas-Junior, Carlos Alberto Ruiz
This work is licensed under a Creative Commons Attribution 4.0 International License.
